Abstract
Loss of cardiomyocytes through programmed cell death is a key event in the development of heart failure, but the inciting molecular mechanisms are largely unknown. We used microarray analysis to identify a genetic program for myocardial apoptosis in Gq-mediated and pressure-overload cardiac hypertrophy. A critical component of this apoptotic program was Nix/Bnip3L. Nix localized to mitochondria and caused release of cytochrome c, activation of caspase-3 and apoptotic cell death, when expressed in HEK293 fibroblasts. A previously undescribed truncated Nix isoform, termed sNix, was not targeted to mitochondria but heterodimerized with Nix and protected against Nix-mediated apoptosis. Forced in vivo myocardial expression of Nix resulted in apoptotic cardiomyopathy and rapid death. Conversely, sNix protected against apoptotic peripartum cardiomyopathy in Gαq-overexpressors. Thus, Nix/Bnip3L is upregulated in myocardial hypertrophy, and is both necessary and sufficient for Gq-mediated apoptosis of cardiomyocytes and resulting hypertrophy decompensation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
MacLellan, W.R. & Schneider, M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81, 137–144 (1997).
Narula, J. et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335, 1182–1189 (1996).
Olivetti, G. et al. Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131–1141 (1997).
Mallat, Z. et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N. Engl. J. Med. 335, 1190–1196 (1996).
Adams, J.W. et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 95, 10140–10145 (1998).
Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189–198 (1999).
Levy, D. et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561–1566 (1990).
Chien, K.R. Molecular advances in cardiovascular biology. Science 260, 916–917 (1993).
Williams, R.S. Apoptosis and heart failure. N. Engl. J. Med. 341, 759–760 (1999).
Thornberry, N.A. & Lazebnik, Y. Caspases: Enemies within. Science 281, 1312–1316 (1998).
MacLellan, W.R. & Schneider, M.D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62, 289–319 (2000).
Schneider, M.D. & Schwartz, R.J. Chips ahoy: Gene expression in failing hearts surveyed by high-density microarrays. Circulation 102, 3026–3027 (2000).
D'Angelo, D.D. et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. USA 94, 8121–8126 (1997).
Offermanns, S. et al. Embryonic cardiomyocyte hypoplasia and craniofacial defects in Gαq/Gα11-mutant mice. EMBO J. 17, 4304–4312 (1998).
Akhter, S.A. et al. Targeting the receptor–Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574–577 (1998).
Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 7, 1236–1240 (2001).
Sakata, Y. et al. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mice. Circulation 97, 1488–1495 (1998).
De Windt, L.J. et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circ. Res. 86, 255–263 (2000).
Aronow, B.J. et al. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol. Genomics 6, 19–28 (2001).
Chen, G. et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J. Biol. Chem. 274, 7–10 (1999).
Adams, J.W. et al. Cardiomyocyte apoptosis induced by Gαq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ.Res. 87, 1180–1187 (2000).
Shi, Y. A structural view of mitochondria-mediated apoptosis. Nat. Struct. Biol. 8, 394–401 (2001).
Subramaniam, A. et al. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613–24620 (1991).
Chien, K.R., Knowlton, K.U., Zhu, H. & Chien, S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J. 5, 3037–3046 (1991).
Ray, R. et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J. Biol. Chem. 275, 1439–1448 (2000).
Chen, G. et al. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186, 1975–1983 (1997).
Mirsky, I. Left ventricular stresses in the intact human heart. Biophys. J. 9, 189–208 (1969).
Katz, A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 322, 100–110 (1990).
Zhang, D. et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6, 556–563 (2000).
Cook, S.A., Sugden, P.H. & Clerk, A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: Association with changes in mitochondrial membrane potential. Circ. Res. 85, 940–949 (1999).
Leri, A. et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin–angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 101, 1326–1342 (1998).
Misao, J. et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94, 1506–1512 (1996).
Geisterfer-Lowrance, A.A. et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272, 731–734 (1996).
Fatkin, D. et al. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene. J. Clin. Invest. 103, 147–153 (1999).
Bruick, R.K. Expression of the gene encoding the pro-apoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97, 9082–9087 (2000).
Yasuda, M. et al. BNIP3α: A human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res. 59, 533–537 (1999).
Acknowledgements
This work was supported by US National Institutes of Health grants HL58010 and HL59888.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Yussman, M., Toyokawa, T., Odley, A. et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8, 725–730 (2002). https://doi.org/10.1038/nm719
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm719
This article is cited by
-
Screening and identification of potential key biomarkers for glucocorticoid-induced osteonecrosis of the femoral head
Journal of Orthopaedic Surgery and Research (2023)
-
Inner mitochondrial membrane protein Prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy
Scientific Reports (2023)
-
RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria
Cell Death & Differentiation (2022)
-
Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance
Angiogenesis (2022)
-
STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma
Cell Death & Disease (2021)